Navamedic Investor Relations Material
Latest events
Q4 2023
Navamedic
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Navamedic
Access all reports
Segment Data
Access more data
Revenue by
Geography
Norway
Sweden
Denmark
Finland
Other
Expenses by
Financials
Navamedic ASA is a Norwegian pharmaceutical company developing, producing, marketing and selling prescription and non-prescription pharmaceuticals, medical nutrition products and medical devices in the Nordic region. The company offers prescription products for use in the treatment of a variety of conditions including: phenylketonuria; homocystinuria; maple syrup urine disease; tyrosinemia, methylmalonic acidemia/propionic acidemia; glutaric aciduria, isovaleric acidemia and urea cycle disorders.
Key slides for Navamedic
Q3 2023
Navamedic
Q4 2023
Navamedic
Latest articles
Puig's 2024 IPO: Paco Rabanne, Jean Paul Gaultier, and Beyond
Explore Puig's journey from its 1914 inception to a 2024 IPO, showcasing its growth, strategic acquisitions, and impact in the beauty and fashion industry.
15 Apr 2024
Alphabet's Unstoppable Rise: From Stanford to Global Tech Leader
Discover Alphabet's rise from a university project to a global tech leader, highlighting its growth, diversification, and visionary leadership.
15 Apr 2024
Companies That Had Their IPO in 2022: War, Inflation and Interest Rates
The stock market and IPO landscape in 2022 was marked by inflationary pressures, rate hikes, and war that heavily impacted the market sentiment.
15 Apr 2024
Ticker symbol
Country
🇳🇴 Norway